Eclipx share price plummets as McMillian pulls out of takeover
Eclipx shares have dropped 55% to record lows in its second consecutive session
Shares of Australian administrative services provider Eclipx, have plunged to session lows after the company said its net profit for the first five months of FY19 was lower than expected. Eclipx reported its Net profit after tax was down 42.4% compared to last year.
The stock has already fallen 56% on Wednesday and an estimated 65.8% this year.
McMillan calls off takeover
Eclipx's merger with McMillan was called off, after McMillian Shakespeare backed out the takeover, citing Eclipx's poor results as a contributing factor.
In response, McMillan’s shares jumped on Thursday, despite calling off the merger.
McMillan's share price jumped 4.31% to $13.30 at time of writing on Thursday.
Eclipx share price
Eclipx's share price at time of writing has fallen to a record low of $0.825, with an estimated 9.4 million shares traded in just a few hours. This follows the company posting its worst intraday drop to date, making it the largest loser on the ASX200 benchmark.
Eclipx announced the merger with McMillian failed after they were not able to reach an agreement with McMillian on the terms of their proposed scheme. McMillian cited a loss of confidence in Eclipx, after their dismal net profit earnings. The company said in a statement:
‘In the circumstances we don’t think that extending the end date set out in the current scheme documents will resolve these issues, nor do we believe it is in the best interests of McMillian Shakespeare.’
Despite the massive drop in their share price, Eclipx have said they are expecting their FY19 result for their Fleet and Novated businesses to be in line with their results from the previous year.
Eclipx's Fleet and Novated businesses generation $61.2 million net profit after tax and amortisation last year.
This information has been prepared by IG, a trading name of IG Markets Limited. In addition to the disclaimer below, the material on this page does not contain a record of our trading prices, or an offer of, or solicitation for, a transaction in any financial instrument. IG accepts no responsibility for any use that may be made of these comments and for any consequences that result. No representation or warranty is given as to the accuracy or completeness of this information. Consequently any person acting on it does so entirely at their own risk. Any research provided does not have regard to the specific investment objectives, financial situation and needs of any specific person who may receive it. It has not been prepared in accordance with legal requirements designed to promote the independence of investment research and as such is considered to be a marketing communication. Although we are not specifically constrained from dealing ahead of our recommendations we do not seek to take advantage of them before they are provided to our clients. See full non-independent research disclaimer and quarterly summary.
Live prices on most popular markets